Unexpectedly, the variants in ZNF224 and PCK1 show opposite directions of allelic effects for association with AD intermediate phenotypes in our cohort compared to their association with AD diagnosis in the initial GWA studies. This evidence concerns the gene PCK1 and Alzheimer disease.